Treatment

Revival of Psychedelic Research: Promising Therapeutic Potential for Depression, PTSD, and More

Psychedelic substances like LSD, psilocybin, mescaline, and ayahuasca have been studied since the 1940s for their potential to treat psychiatric disorders. After a global ban in the 1970s,...
Picture of Marissa R. DiMambro,
Marissa R. DiMambro,
DNP, PMHNP-BC
Psychiatric Mental Health Nurse Practitioner, H3-Hope, Healing, and Health, Inc.
Read More

Comparing Lithium and Divalproex for Late-life Bipolar Disorder

Bipolar disorder in late life presents significant challenges due to high rates of medical service use, disability, increased mortality, and...
Katie Halter,
CURATED BY:
Katie Halter,
MSc, PA-C, CAQ-Psych
Read More >

Antidepressant Use in Bipolar Disorder: Clinical Considerations

The use of antidepressants in bipolar disorder (BD) remains a controversial topic despite their widespread use. They are often recommended...
Lanie Fercilien,
CURATED BY:
Lanie Fercilien,
PA-C
Read More >

Lithium and Antiepileptics Reduce Suicide Risk in Bipolar Disorder, Increased Risk After Discontinuation

This study aimed to investigate the relationship between mood stabilizing treatments and the risk of suicide attempts in patients with...
Lanie Fercilien,
CURATED BY:
Lanie Fercilien,
PA-C
Read More >

Remote CBT Provides Comparable Benefits With Lower Burden for Youth with Mood Disorders

This study compared in-person and remote group cognitive behavioral therapy (CBT) for adolescents with mood disorders or psychosis-risk syndromes. Participants...
Jordan P. Roberts,
CURATED BY:
Jordan P. Roberts,
PA-C
Read More >

Lamotrigine-Induced TEN in Bipolar II: A Case for Caution and Gradual Titration

Toxic epidermal necrolysis (TEN) is a severe skin disorder often triggered by drug reactions, with Lamotrigine being a common culprit,...
Marissa R. DiMambro,
CURATED BY:
Marissa R. DiMambro,
DNP, PMHNP-BC
Read More >

Emotional Improvements and Subgroup Preferences in Bipolar I Disorder Treatment Goal

This study aimed to quantify treatment goals for the pharmacological management of Bipolar I disorder (BP-I) in adults in the...
Marissa R. DiMambro,
CURATED BY:
Marissa R. DiMambro,
DNP, PMHNP-BC
Read More >
Privacy Policy
Your Privacy Choices
Terms of Use
Company
Contact
Partner with Us
Ambassador Program

© 2025 POCN—an IQVIA business. All Rights Reserved.

Share